Objective The World Maternal Antifibrinolytic (WOMAN) Trial was the first in the UK to use
the option of waiver of informed consent at the time of an obstetric emergency. This …

Objective To identify factors affecting the decision of pregnant women to withhold their
consent to Design A qualitative, cross‐sectional, retrospective study using semi‐structured …

Background Obtaining prospective written consent from women to participate in trials when
they are experiencing an obstetric emergency is challenging. Alternative consent pathways …

Background Recruitment to intrapartum research is complex. Women are expected to
understand unfamiliar terminology and assess potential harm versus benefit to their baby …

Abstract Service users within the NHS are increasingly being asked to participate in clinical
research. In Liverpool Women's NHS Foundation Trust, approximately 35% of women take …

Abstract Background The Cord Pilot Trial compared alternative policies for timing of cord
clamping at very preterm birth at eight UK hospitals. In addition to standard written consent …

Background Pregnant women were excluded from clinical trials until the 1990s, but the Food
and Drug Administration nowadays allows-and even encourages-responsible inclusion of …

The new Research Governance Framework places emphasis upon gaining fully informed
consent from all potential research participants. In obstetric practice, research projects often …

There is increasing global pressure to ensure that pregnant women are responsibly and
safely included in clinical research in order to improve the evidence base that underpins …

Background Increasingly, the sharing of study results with participants is advocated as an
element of good research practice. Yet little is known about how receiving the results of trials …